Home Cart Sign in  
Chemical Structure| 198561-07-8 Chemical Structure| 198561-07-8
Chemical Structure| 198561-07-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fmoc-Pra-OH is an alanine derivative, widely used in peptide synthesis.

Synonyms: Fmoc-Pra-OH

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fmoc-Pra-OH

CAS No. :198561-07-8
Formula : C20H17NO4
M.W : 335.35
SMILES Code : C#CC[C@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C(O)=O
Synonyms :
Fmoc-Pra-OH
MDL No. :MFCD01075095
InChI Key :DJGMNCKHNMRKFM-SFHVURJKSA-N
Pubchem ID :2734461

Safety of Fmoc-Pra-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Fmoc-Pra-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 198561-07-8 ]

[ 198561-07-8 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 29022-11-5 ]
  • [ 71989-31-6 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Pro-Asp-Phe-Gly-OH [ No CAS ]
  • 2
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 71989-23-6 ]
  • [ 198561-07-8 ]
  • Ac-Ile-Asp-Phe-Gly-OH [ No CAS ]
  • 3
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 162558-25-0 ]
  • [ 198561-07-8 ]
  • Ac-(L)-Dapa-Asp-Phe-Gly-OH [ No CAS ]
  • 4
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • Fmoc-Trp-OH [ No CAS ]
  • [ 198561-07-8 ]
  • Ac-Trp-Asp-Phe-Gly-OH [ No CAS ]
  • 5
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 71989-33-8 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Ser-Asp-Phe-Gly-OH [ No CAS ]
  • 6
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 73731-37-0 ]
  • [ 198561-07-8 ]
  • Ac-Thr-Asp-Phe-Gly-OH [ No CAS ]
  • 7
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 71989-20-3 ]
  • [ 198561-07-8 ]
  • Ac-Gln-Asp-Phe-Gly-OH [ No CAS ]
  • 8
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 132327-80-1 ]
  • [ 198561-07-8 ]
  • Ac-Gln-Asp-Phe-Gly-OH [ No CAS ]
  • 9
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Asp-Asp-Phe-Gly-OH [ No CAS ]
  • 10
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 119831-72-0 ]
  • [ 198561-07-8 ]
  • Ac-Arg-Asp-Phe-Gly-OH [ No CAS ]
  • 11
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid [ No CAS ]
  • [ 198561-07-8 ]
  • Ac-Hyp-Asp-Phe-Gly-OH [ No CAS ]
  • 12
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 71989-28-1 ]
  • [ 198561-07-8 ]
  • Ac-Met(O2)-Asp-Phe-Gly-OH [ No CAS ]
  • 13
  • [ 29022-11-5 ]
  • [ 112883-29-1 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Tyr-Asp-Phe-Gly-OH [ No CAS ]
  • 14
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 71989-38-3 ]
  • [ 198561-07-8 ]
  • Ac-Tyr-Asp-Phe-Gly-OH [ No CAS ]
  • 15
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • 9-fluorenylmethoxycarbonyl-Nim-trityl-L-histidine [ No CAS ]
  • [ 198561-07-8 ]
  • Ac-His-Asp-Phe-Gly-OH [ No CAS ]
  • 16
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • 9-fluorenylmethoxycarbonyl-Nim-trityl-L-histidine [ No CAS ]
  • [ 100-46-9 ]
  • [ 198561-07-8 ]
  • Ac-Asp-Asp(NHBn)-Phe-Gly-OH [ No CAS ]
  • 17
  • [ 29022-11-5 ]
  • [ 35661-39-3 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Ala-Asp-Phe-Gly-OH [ No CAS ]
  • 18
  • [ 29022-11-5 ]
  • [ 68858-20-8 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Val-Asp-Phe-Gly-OH [ No CAS ]
  • 19
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Pra-Phe-Gly-OH [ No CAS ]
  • 20
  • [ 29022-11-5 ]
  • [ 35661-40-6 ]
  • [ 108-24-7 ]
  • [ 198561-07-8 ]
  • Ac-Asp-Phe-Gly-OH [ No CAS ]
  • 22
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C35H60N8O7 [ No CAS ]
  • 23
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C41H71N9O8 [ No CAS ]
  • 24
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C23H38N6O5 [ No CAS ]
  • C46H76N12O10 [ No CAS ]
  • 25
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C29H49N7O6 [ No CAS ]
  • C58H98N14O12 [ No CAS ]
  • 26
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C35H60N8O7 [ No CAS ]
  • C70H120N16O14 [ No CAS ]
  • 27
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C41H71N9O8 [ No CAS ]
  • 28
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C34H54N10O8 [ No CAS ]
  • 29
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C17H27N5O4 [ No CAS ]
  • 30
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C23H38N6O5 [ No CAS ]
  • 31
  • [ 35661-60-0 ]
  • [ 79410-33-6 ]
  • [ 198561-07-8 ]
  • C29H49N7O6 [ No CAS ]
  • 32
  • [ 198561-07-8 ]
  • [ 1056967-18-0 ]
  • 33
  • [ 1738-68-7 ]
  • [ 198561-07-8 ]
  • [ 1134204-65-1 ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; Example 6 Peptide Syntheses and Characterization General Procedures. Coupling of Fmoc-amino acid to amine groups of acid protected amino acid was performed with 2 equiv Fmoc-Amino Acid and 2 equiv TBTU and 4 equv. DIPEA in DMF at rt. Fmoc deprotection was achieved with 20percent piperidine in DMF; Fmoc-NH-Pra-Gly-O-Bn (3). 1H NMR (300 MHz, CDCl3): delta 7.76 (d, 2 H, J = 7.5 Hz), 7.59 (d, 2 H, J= 7.5 Hz), 7.40 (q, 4 H, J= 7.5 Hz), 7.33 (m, 5 H), 5.58 (d,1 H, J = 6.6 Hz), 4.45 (d, 2 H, J = 6.8 Hz), 4.40 (m, 2 H), 4.23 (t, 1 H, J = 6.8 Hz), 4.10 (d, 2 H, J = 6.6 Hz), 2.82 (d, 1 H, J= 15.4 Hz), 2.72 (d, 1 H, J = 15.4 Hz), 2.07 (t, 1 H, J= 2.6 Hz); 13C NMR (75 MHz, CDCl3): delta 169.8, 168.2, 155.9, 143.7, 141.3, 131.0, 128.7, 128.6, 127.8, 127.1, 125.0, 120.1, 79.0, 72.0, 67.4, 67.3, 53.3, 47.1, 41.5; EIMS: calcd. for C29H27N2O5+ 483.18 Found: 483.33 (M+H)+.
  • 34
  • C6H13N2OPol [ No CAS ]
  • [ 198561-07-8 ]
  • C26H28N3O4Pol [ No CAS ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; General procedure for solid phase peptide synthesis.; MBHA resin (0.66 mmol/g, 1 eq) was pre-swollen in DMF. 20percent piperidine in DMF was added to them and the suspension was stirred at room temperature for 1 h. The resin was washed with DCM, DMF and dried. Coupling of Fmoc-amino acid to amino groups was performed with 3 equiv Fmoc-AAcid and 3 equiv TBTU, 3 equv. DIPEA in DMF.Fmoc deprotection was effected with 20percent piperidine in DMF for 2 x 30 min followed by washing of the resin six times with DMF. The resin was washed six times with the appropriate solvent between each reaction step. A small portion of the resin was subjected with TFA and detected by mass spectra. Then deprotection and coupling was performed in similar way.
  • 35
  • [ 1159265-95-8 ]
  • [ 198561-07-8 ]
  • [ 1159265-97-0 ]
 

Historical Records

Categories